GC Wealth Management RIA’s Soleno Therapeutics SLNO Stock Holding History

GC Wealth Management RIA’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,027	Closed	-$671K	–	535
2026 Q1	$671K	Buy	+20,027	New	+$785K	0.03%	302

GC Wealth Management RIA's SLNO Position: Q2 2026 in Review

GC Wealth Management RIA sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 20,027 shares — an estimated $671K sold.

GC Wealth Management RIA first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $671K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

GC Wealth Management RIA reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
GC Wealth Management RIA sold 20,027 Soleno Therapeutics shares in Q2 2026, an estimated $671K.
GC Wealth Management RIA first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
GC Wealth Management RIA's Soleno Therapeutics position peaked at $671K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on GC Wealth Management RIA's 13F filing for Q2 2026, filed 16 Jul 2026.